Marshall Wace »

Monte Rosa Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-09-30 $921k 174k 5.30

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Microsoft Corp Common Stock (MSFT)
Amazon.com Equity Option Put Option (AMZN)
Apple Common Stock (AAPL)
Meta Platforms-a Common Stock (META)
Nvidia Corp Common Stock (NVDA)
Alphabet Inc-a Common Stock (GOOGL)
Tesla Common Stock (TSLA)
Flutter Enter-di Common Stock (FLUT)
Johnson&johnson Common Stock (JNJ)
Eli Lilly & Co Common Stock (LLY)
Boston Scientifc Common Stock (BSX)
Broadcom Common Stock (AVGO)
Spdr Gold Trust Equity Option Call Option (GLD)

View all positions for Marshall Wace

Top funds holding Monte Rosa Therapeutics

NEA Management Company
T. Rowe Price Associates
Baker Bros. Advisors
BlackRock
Suvretta Capital Management
Vanguard Group
BlackRock
Aisling Capital Management
Alphabet
Citadel Advisors
Geode Capital Management
Vestal Point Capital
State Street Corporation
Parkwood
ExodusPoint Capital Management

View all funds holding Monte Rosa Therapeutics